Adjusting for age, sex, race/ethnicity, income, education, and food security status, individuals experiencing nutrition insecurity were 4060 % more likely to have obesity as well as type 2 diabetes, heart disease, hypertension, and hypercholesterolemia
Navigating these social changes is an important but often overlooked aspect of the GLP-1 transformation journey
Peak also asks the eating-disorder screen (anorexia or bulimia) and the pancreatitis and type-1 diabetes knockouts on the same screen
It analyzes pathway-level variants (GLP1R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction
However, injection site reactions can be a problem for some people using GLP-1 agonists
The therapeutic effect of GLP-1RAs on neurological diseases has been confirmed by several studies